NEVVI Medicare utilization intelligence

← back

CARSON, CRAIGM.D. NPI 1043288673 Clinician

Rheumatology · EDMOND, OK

Specialty Rheumatology — from billed Medicare claims
Trained UNIVERSITY OF UTAH SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 41 years since medical school (class of 1985, self-reported to CMS)
Location EDMOND, OK · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 56 codes billed · 130,069 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2007-07

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J1602 Injection, golimumab, 1 mg, for intravenous use premiumpremium premiumpremium
J3262 Injection, tocilizumab, 1 mg premiumpremium premiumpremium
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) premiumpremium premiumpremium
J1745 Injection, infliximab, excludes biosimilar, 10 mg premiumpremium premiumpremium
J3111 Injection, romosozumab-aqqg, 1 mg premiumpremium premiumpremium
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) premiumpremium premiumpremium
J0490 Injection, belimumab, 10 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg premiumpremium premiumpremium
J9312 Injection, rituximab, 10 mg premiumpremium premiumpremium
J2919 Injection, methylprednisolone sodium succinate, 5 mg premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
80053 Blood test, comprehensive group of blood chemicals premiumpremium premiumpremium
85652 Red blood cell sedimentation rate, to detect inflammation, automated premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
86140 Measurement c-reactive protein for detection of infection or inflammation premiumpremium premiumpremium
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
J2405 Injection, ondansetron hydrochloride, per 1 mg premiumpremium premiumpremium
77085 Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
J1885 Injection, ketorolac tromethamine, per 15 mg premiumpremium premiumpremium
86235 Measurement of antibody for assessment of autoimmune disorder, any method premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
86480 Tuberculosis test, gamma interferon premiumpremium premiumpremium
J3489 Injection, zoledronic acid, 1 mg premiumpremium premiumpremium
72148 Mri scan of lower spinal canal without contrast premiumpremium premiumpremium
73130 X-ray of hand, minimum of 3 views premiumpremium premiumpremium
72141 Mri scan of upper spinal canal without contrast premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
73560 X-ray of knee, 1-2 views premiumpremium premiumpremium
70551 Mri scan of brain without contrast premiumpremium premiumpremium
86200 Measurement of antibody for rheumatoid arthritis assessment premiumpremium premiumpremium
86431 Rheumatoid factor level premiumpremium premiumpremium
86803 Hepatitis c antibody measurement premiumpremium premiumpremium
87340 Detection test by immunoassay technique for hepatitis b surface antigen premiumpremium premiumpremium
73120 X-ray of hand, 2 views premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
82570 Creatinine level to test for kidney function or muscle injury premiumpremium premiumpremium
84550 Uric acid level, blood premiumpremium premiumpremium
86706 Hepatitis b surface antibody measurement premiumpremium premiumpremium
86704 Hepatitis b core antibody measurement premiumpremium premiumpremium
73721 Mri scan of leg joint without contrast premiumpremium premiumpremium
86038 Screening test for autoimmune disorder premiumpremium premiumpremium
81003 Automated urinalysis test premiumpremium premiumpremium
82306 Vitamin d-3 level premiumpremium premiumpremium
70553 Mri scan of brain before and after contrast premiumpremium premiumpremium
86225 Measurement of dna antibody, native or double stranded premiumpremium premiumpremium
80307 Testing for presence of drug, by chemistry analyzers premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.